Suchergebnisse - "Lippman, Scott M"

PubPharm (697)

1

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy

enthalten in: iScience | 2024

von Fujiwara, Y. | Kato, S. | Nishizaki, D. | +8

2

If it's a target, it's a pan-cancer target : Tissue is not the issue

enthalten in: Cancer treatment reviews | 2024

von Adashek, J. | Kato, S. | Sicklick, J. | +2

3

A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer

enthalten in: Science translational medicine | 2024

von Miller, A. | Koşaloğlu-Yalçın, Z. | Westernberg, L. | +17

4

CHROMOSOME 9P24 LOSS AND GAIN PREDICTS RESISTANCE AND BENEFIT OF IMMUNE CHECKPOINT INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von LIPPMAN SCOTT M | CAVENEE WEBSTER K | DAVOLI TERESA | +1

5

CHROMOSOME 9P24 LOSS AND GAIN PREDICTS RESISTANCE AND BENEFIT OF IMMUNE CHECKPOINT INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von LIPPMAN SCOTT M | CAVENEE WEBSTER K | DAVOLI TERESA | +1

6

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer : The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

enthalten in: Gastroenterology | 2024

von Rodriguez, N. | Furniss, C. | Yurgelun, M. | +25

7

High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome

enthalten in: Therapeutic advances in medical oncology | 2024

von Krishnamurthy, N. | Nishizaki, D. | Lippman, S. | +7

8

Nivolumab for Patients With High-Risk Oral Leukoplakia : A Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2024

von Hanna, G. | Villa, A. | Nandi, S. | +21

CommentOn: JAMA Oncol. 2024 Jan 1;10(1):41-42. - PMID 37971752

9

Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity

enthalten in: Cancer medicine | 2023

von Lim, J. | Kurzrock, R. | Nishizaki, D. | +9

10

METHODS AND BIOMARKERS IN CANCER

enthalten in: Europäisches Patentamt | 2023

von DAVOLI TERESA | LIPPMAN SCOTT M | CAVENEE WEBSTER K

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[70]